Merkel cell carcinoma: a review of clinical management with focus on Asian patients

被引:4
作者
Nakano, Eiji [1 ,2 ]
Ogata, Dai [1 ]
Namikawa, Kenjiro [1 ]
Yamazaki, Naoya [1 ]
机构
[1] Natl Canc Ctr, Dept Dermatol Oncol, 5-1-1,Tsukiji,Chuo ku, Tokyo, Japan
[2] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
关键词
Merkel cell carcinoma; radiation; immune checkpoint inhibitor; peptide receptor radionuclide therapy; Asia; RADIATION-THERAPY; OPEN-LABEL; DEFINITIVE RADIOTHERAPY; ADJUVANT RADIOTHERAPY; POLYOMAVIRUS; CHEMOTHERAPY; SURVIVAL; NIVOLUMAB; DIAGNOSIS; RESECTION;
D O I
10.1093/jjco/hyad059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Merkel cell carcinoma is a highly aggressive skin cancer characterized by neuroendocrine differentiation. This review aimed to present updates on the knowledge and current trends of clinical management of Merkel cell carcinoma. Additionally, we focused on Asian reports of Merkel cell carcinoma because most skin cancers differ substantially between Caucasians and Asians, and researchers have reported differences in Merkel cell carcinoma in racial and ethnic groups. Owing to its rarity, there is limited evidence for the epidemiology, pathogenesis, diagnosis and Merkel cell carcinoma treatment. The development of a nationwide survey or cancer registry, the identification of Merkel cell polyomavirus and the use of immune checkpoint inhibitors allowed a better understanding of its characteristics and biology and have revolutionized the clinical management of patients with Merkel cell carcinoma. Its incidence has gradually increased worldwide; however, it depends on the geographic location, race and ethnicity. No randomized prospective studies have evaluated the significance of sentinel lymph node biopsy, complete lymph node dissection and adjuvant radiation therapy; however, most patients with localized Merkel cell carcinoma are treated surgically or with post-operative radiation. Patients with distant Merkel cell carcinoma are administered immune checkpoint inhibitors as the first-line therapy; however, there is no established second-line therapy for refractory Merkel cell carcinoma. Furthermore, it is necessary to validate the favorable results of clinical studies performed in Western countries in the patients in Asia. Merkel cell carcinoma is a rare aggressive cutaneous neuroendocrine carcinoma. We reviewed recent updates of the pathogenesis and clinical management and focused on Asian patients who have limited evidence.
引用
收藏
页码:673 / 679
页数:7
相关论文
共 66 条
[1]   High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma [J].
Akaike, T. ;
Qazi, J. ;
Anderson, A. ;
Behnia, F. S. ;
Shinohara, M. M. ;
Akaike, G. ;
Hippe, D. S. ;
Thomas, H. ;
Takagishi, S. R. ;
Lachance, K. ;
Park, S. Y. ;
Tarabadkar, E. S. ;
Iyer, J. G. ;
Blom, A. ;
Parvathaneni, U. ;
Vesselle, H. ;
Nghiem, P. ;
Bhatia, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (02) :319-327
[2]   Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review [J].
Askari, Emran ;
Moghadam, Soroush Zarehparvar ;
Wild, Damian ;
Delpassand, Ebrahim ;
Baldari, Sergio ;
Nilica, Bernhard ;
Hartrampf, Philipp E. ;
Kong, Grace ;
Grana, Chiara Maria ;
Walter, Martin Alexander ;
Capoccetti, Francesca ;
Kasi, Pashtoon Murtaza ;
Strosberg, Jonathan .
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2023, 51 (01) :22-25
[3]   Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC): Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial [J].
Becker, J. C. ;
Ugurel, S. ;
Leiter-Stoppke, U. ;
Meier, F. ;
Gutzmer, R. ;
Haferkamp, S. ;
Zimmer, L. ;
Livingstone, E. ;
Eigentler, T. ;
Hauschild, A. ;
Kiecker, F. ;
Hassel, J. C. ;
Mohr, P. ;
Fluck, M. ;
Thomas, I. ;
Garzarolli, M. ;
Grimmelmann, I. ;
Drexler, K. ;
Eckhardt, S. ;
Schadendorf, D. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S903-S903
[4]   Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC): A randomized, multicenter DeCOG/ADO study [J].
Becker, Jurgen C. ;
Hassel, Jessica Cecile ;
Menzer, Christian ;
Kahler, Katharina C. ;
Eigentler, Thomas K. ;
Meier, Friedegund Elke ;
Berking, Carola ;
Gutzmer, Ralf ;
Mohr, Peter ;
Kiecker, Felix ;
Kaatz, Martin ;
Windemuth-Kieselbach, Christiane ;
Lorenz-Schlueter, Claudia ;
Zimmer, Lisa ;
Ugurel, Selma ;
Schadendorf, Dirk .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[5]   Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base [J].
Bhatia, Shailender ;
Storer, Barry E. ;
Iyer, Jayasri G. ;
Moshiri, Ata ;
Parvathaneni, Upendra ;
Byrd, David ;
Sober, Arthur J. ;
Sondak, Vernon K. ;
Gershenwald, Jeffrey E. ;
Nghiem, Paul .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (09)
[6]  
Busam KJ., 2018, WHO CLASSIFICATION S, P48
[7]   Genetic profiles of different subsets of Merkel. cell carcinoma show links between combined and pure MCPyV-negative tumors [J].
Carter, Michael D. ;
Gaston, Dan ;
Huang, Weei-Yuarn ;
Greer, Wenda L. ;
Pasternak, Sylvia ;
Thai Yen Ly ;
Walsh, Noreen M. .
HUMAN PATHOLOGY, 2018, 71 :117-125
[8]   Merkel cell carcinoma in Taiwan A series of 24 cases and literature review [J].
Chang, John Wen-Cheng ;
Chang, Yao-Yu ;
Huang, Yen-Lin ;
Lo, Yun-Feng ;
Ho, Tsung-Ying ;
Huang, Yi-Ting ;
Chen, Huan-Wu ;
Yeh, Chun-Nan ;
Wu, Chiao-En .
MEDICINE, 2019, 98 (42) :e17538
[9]   Merkel Cell Polyomavirus Is Frequently Detected in Korean Patients with Merkel Cell Carcinoma [J].
Chun, Seung Min ;
Yun, Sook Jung ;
Lee, Seung-Chul ;
Won, Young Ho ;
Lee, Jee-Bum .
ANNALS OF DERMATOLOGY, 2013, 25 (02) :203-207
[10]   Sentinel lymph node biopsy in Merkel cell carcinoma: Predictors of sentinel lymph node positivity and association with overall survival [J].
Conic, Rosalynn R. Z. ;
Ko, Jennifer ;
Saridakis, Stephanie ;
Damiani, Giovanni ;
Funchain, Pauline ;
Vidimos, Allison ;
Gastman, Brian R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (02) :364-372